• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-VSDMPIHDE-016
Device Problem No Apparent Adverse Event (3189)
Patient Problem Pericardial Effusion (3271)
Event Date 10/15/2020
Event Type  Injury  
Manufacturer Narrative
Further information regarding this event has been requested.The investigation results will be provided in a subsequent submission.
 
Event Description
Post infarct vsd closure procedure.Occluder 9-vsdmpihde-016 was placed successfully.Additional left to right flow was noted adjacent to the occluder.An attempt was then made to pass a wire through the secondary defect next to the occluder.While making the attempt a wire and 6fr multipurpose catheter were noted to pass through the border of the heart on x-ray.At that point an effusion and was noted and perforation through the apex of the heart was apparent.An 8mm 9-avp4-008 was then deployed through the mp catheter to and protamine was given to seal the leak.A drain was placed to eliminate the effusion.The procedure was stopped at that point.On (b)(6) 2020 the patient was taken to the or to surgically repair the remaining defect and replace the mitral valve.The 16mm occluder was well seated and left in the heart and the adjacent defect was patched.The patient is stable.
 
Manufacturer Narrative
An event of pericardial effusion and perforation was reported.A more comprehensive assessment could not be performed as the device remains implanted was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.An initial review of complaints data was reviewed on (b)(6) 2020 as a component of the complaint handling risk review per wi 90591806.Without an identified medical device problem, the aho codes are consistent with the hazards/harms identified for this product family, and no new hazards or harms were identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key10857661
MDR Text Key216844068
Report Number2135147-2020-00484
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
PMA/PMN Number
H070005
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 12/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/17/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9-VSDMPIHDE-016
Device Lot Number7198464
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received12/08/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-